Berlin Launches Academy

WEST BERLIN—The forging of stronger ties among researchers, and between academia and industry, are two important goals of this city’s new Academy of Science (see THE SCIENTIST, March 9, p. 5). The academy, after opening ceremonies later this week, will begin work on a research agenda that will span the natural and medical sciences as well as technology assessment. The first six projects, chosen from 39 proposals and each expected to last three years, will cover automation and the

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WEST BERLIN—The forging of stronger ties among researchers, and between academia and industry, are two important goals of this city’s new Academy of Science (see THE SCIENTIST, March 9, p. 5).

The academy, after opening ceremonies later this week, will begin work on a research agenda that will span the natural and medical sciences as well as technology assessment. The first six projects, chosen from 39 proposals and each expected to last three years, will cover automation and the future workplace, solar energy, environmental standards, the role of innovation in society, gerontology and the exodus of scientists from Berlin during the Third Reich

The Berlin Scnate has promised $4.2 million annually for support of operations and two of the six initial projects. The academy hopes to obtain industrial funding for the other efforts, which will be pursued as resources become available.

Horst Albach, professor of business administration at the universities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies